BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Emonds E, Fitzner B, Jaster R. Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. World J Gastroenterol 2010; 16(16): 1970-1978 [PMID: 20419833 DOI: 10.3748/wjg.v16.i16.1970]
URL: https://www.wjgnet.com/1007-9327/full/v16/i16/1970.htm
Number Citing Articles
Na Shao, Daoxin Ma, Jianbo Wang, Ting Lu, Yuzhu Guo, Chunyan Ji. Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cellsAnnals of Hematology 2013; 92(1): 33 doi: 10.1007/s00277-012-1561-8
Na Shao, Jie Zou, Jie Li, Feng Chen, Jianjian Dai, Xun Qu, Xiulian Sun, Daoxin Ma, Chunyan Ji. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemiaLeukemia & Lymphoma 2012; 53(9): 1769 doi: 10.3109/10428194.2012.663085
Ravi P. Sahu, Sanjay Batra, Prabodh K. Kandala, Thomas L. Brown, Sanjay K. Srivastava. The role of K-Ras gene mutation in TRAIL-induced apoptosis in pancreatic and lung cancer cell linesCancer Chemotherapy and Pharmacology 2011; 67(2): 481 doi: 10.1007/s00280-010-1463-1
Desamparados Roda, Josefa Castillo, Marcelino Telechea-Fernández, Anabel Gil, Gerardo López-Rodas, Luís Franco, Patricia González-Rodríguez, Susana Roselló, J. Alejandro Pérez-Fidalgo, Elena R. García-Trevijano, Andrés Cervantes, Rosa Zaragozá, Matias A Avila. EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer CellsPLOS ONE 2015; 10(6): e0130543 doi: 10.1371/journal.pone.0130543
Ines Zidi, Nidhal Ben Amor. HLA-G regulators in cancer medicine: an outline of key requirementsTumor Biology 2011; 32(6): 1071 doi: 10.1007/s13277-011-0213-2
SUNG OK KIM, MI RYEO KIM. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC-1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activityInternational Journal of Oncology 2013; 42(1): 349 doi: 10.3892/ijo.2012.1686